Notably, PCa antigen 3 (PCA3)—a lncRNA—is a urine-derived biomarker with clinical application in PCa, being overexpressed in 95% of men with primary and metastatic PCa tumors [84]. Here, PCA3 is linked to posterior cortical atrophy.